Survey of drug resistance of Mycobacterium tuberculosis in 3 Mexican states, 1997

Archives of Internal Medicine

Volumn 160, Issue 5, 2000, Pages 639-644

  Granich, Reuben M ^a   Balandrano, Susana ^c   Santaella, Adalberto J ^c   Binkin, Nancy J ^a   Castro, Kenneth G ^a   Marquez Fiol, Alma ^c   Anzaldo, Georgina ^c   Zarate, Margarita ^c   Jaimes, Maria Luisa ^c   Velazquez Monroy, Oscar ^c   Salazar, Lourdes ^c   Alvarez Lucas, Carlos ^c   Kuri, Pablo ^c   Flisser, Ana ^c   Santos Preciado, Jose ^c   Ruiz Matus, Cuauhtemoc ^c   Tapia Conyer, Roberto ^c   Tappero, Jordan W ^a,b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHILD; DRUG SURVEILLANCE PROGRAM; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RETREATMENT; SPUTUM SMEAR; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 0034642955     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.5.639     Document Type: Article

References (27)

1. Raviglione MC, Snider DE, Kochi A. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA. 1995;273:220-226.
2. World Health Organization. Treatment of Tuberculosis: Guidelines for National Programmes. Geneva, Switzerland: World Health Organization; 1997. Report WHO/ TB/97.220.
3. Pablos-Mendez A, Raviglione MC, Laszlo A, et al, for the World Health Organization -International Union Against Tuberculosis and Lung Disease Working Group on Anti-tuberculosis Drug Resistance Surveillance. Global surveillance for antituberculosis-drug resistance, 1994-1997. N Engl J Med. 1998;338:1641-1649.
4. Goble M, Iseman MD, Madsen LA, et al. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med. 1993;328: 527-532.
5. Frieden TR, Sterling T, Pablos-Mendez A, Kilburn J, Cauthen G, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med. 1993; 328:521-652.
6. Coronado VG, Beck-Sague CM, Mutton MD, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis. 1993;168:1052-1055.
7. Edlin B, Tokars JI, Rieco MH, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992;326:1514-1521.
8. World Health Organization. Anti-tuberculosis Drug Resistance in the World: The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 1994-1997. Geneva, Switzerland: WHO Global Tuberculosis Programme: 1997. Report WHO/TB/97.229.
9. Cohn ML, Middlebrook G, Russel WF Jr. Combined drug treatment of tuberculosis, I: prevention of emergence of mutant populations of tubercle bacilli resistant to both streptomycin and isoniazid in vitro. J Clin Invest. 1959;38:1349-1355.
10. Mahmoudi A, Iseman MD. Pitfalls in the care of patients with tuberculosis: common efforts and their association with the acquisition of drug resistance. JAMA. 1993;270:65-68.
11. Crofton J, Chaulet P, Maher D, et al. Guidelines for the Management of Drug-Resistant Tuberculosis. Geneva, Switzerland: World Health Organization; 1997. Publication WHO/GTB/96.210.
12. Manual de Procedimientos, Programa de Prevención y Control de la Tuberculosis. Mexico City, Mexico: Programa de Prevención y Control de Microbacterias, Coordinación de Vigilancia Epidemiológica, Subsecretaria de Prevención y Control de Enfermedades, Secretaria de Salud; 1999.
13. Inderlied CB, Salfinger M. Antimicrobial agents and susceptibility tests: mycobacteria. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology. 6th ed. Washington, DC: ASM Press; 1995: 1392-1396.
14. Sifuentes-Osornio J, Ponce-de-Leon LA, Camacho-Mezquita FE, et al. Drug resistance of M. tuberculosis in Mexican patients, I: clinical manifestations and risk factors. Rev Invest Clin. 1995;47:273-281.
15. Sistema Nacional de Vigilancia Epidemiológica. Bol Epidemiol (Sist Nacl Vigilancia Epidemiol). December 23, 1997:53:31-33.
16. Sanchez-Perez HJ, del Mar Garcia GM, Halperin D. Pulmonary tuberculosis in the border region of Chiapas, Mexico, Int J Tuberc Lung Dis. 1998;2:37-43.
17. Laszlo A, Kantor IN. A random sample survey of initial drug resistance among tuberculosis cases in Latin America. Bull World Health Organ. 1994;84:603-610.
18. Peter CR, Schultz E, Moser K, et al. Drug-resistant pulmonary tuberculosis in the Baja California-San Diego County border population. West J Med. 1998;169: 208-213.
19. Garcia-Garcia ML, Valdespino-Gomez JL, Palacios-Martinez M, et al. Tuberculosis and AIDS in Mexico. Salud Publica Mex. 1995;37:539-548.
20. Small PM, Shafer RW. Hopewell PC, et al. Exogenous reinfection with multidrug-resistant M. tuberculosis in patients with advanced HIV infection. N Engl J Med. 1993;328:1137-1144.
21. Granich R, Moore M, Binkin N, McCray E. Drug resistance among U.S. foreign-born TB cases, 1993-1996. Presented at: the Third Annual Meeting, North American Region, Union Against Tuberculosis and Lung Disease; February 26-28, 1998; Vancouver, British Columbia. Abstract D.FIR.9.
22. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med. 1994; 149:1359-1374.
23. Weis S, Slocum P, Blais FX, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med. 1994;330: 1179-1184.
24. Moore M, Onorato IM, McCray E, et al. Trends in drug-resistant tuberculosis in the United States, 1993-1996. JAMA. 1997;278:833-837.
25. McKenna MT, McCray E, Jones JL, et al. The fall after the rise: tuberculosis in the United States, 1991 to 1994. Am J Public Health. 1998;88:1059-1063.
26. Farmer PE, Bayona J, Becerra M, et al. The dilemma of MDR-TB in the global era. Int J Tuberc Lung Dis. 1998;2:869-876.
27. Farmer PE, Nardell E. Nihilism and pragmatism in tuberculosis control. Am J Public Health. 1998;88:1014-1015.